Neurofibromatosis type II
|
(Schwannomatosis of the 8th nerve)
Prevalence: 1/40,000 to 1/100.000.
Autosomal dominant transmission of a mutation of the NF2 gene on 22q12 but de novo mutations are observed in 50% of cases. If de novo mutation appears during embryogenesis, only certain cells carry it (Mosaic). This gene codes for a protein called merlin or schwannonim which inhibits the growth of some tumors. In general, patients become symptomatic in their third decade.
Manifestations:
- often bilateral acoustic (90%) neuroma (Schwannoma); neuropathies of other cranial nerves, retinal glioma, meningioma or spinal ependymoma
- juvenile cataract (60%), retinitis pigmentosa
- subcutaneous schwannomas and neurofibromas
Sometimes: cutaneous spots that are either, pigmented and hairy or depigmented and glabrous.
Anesthetic implications:
deafness; nerve tumors; sometimes paraplegia.
References :
Updated: November 2018